EUVIMEDEUVIMED entdecken
Crossref

L26/P-060 Influence of sperm quality on blastocyst development across artificial intelligence (AI)-derived oocyte quality strata: a retrospective study

N. Yesilada, Z. Atayurt, G. Raad, G. Liperis, Z. Yarkiner, O. Ammar, Y. Yilancilar, B. Yuksel, M. Serdarogullari

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.396 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von N. Yesilada und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does sperm quality influence blastocyst development when oocytes are stratified by an AI-derived oocyte quality score? Summary answer Reduced sperm quality was associated with lower odds of blastocyst and good-quality blastocyst development even among oocytes with high AI-derived quality scores, compared with normozoospermia. What is known already AI-based tools such as MAGENTA have been developed to assess oocyte quality from imaging data and to estimate blastocyst development in intracytoplasmic sperm injection (ICSI) cycles. The model assigns a score ranging from 0 to 10, with higher scores associated with increased blastocyst development. In parallel, reduced sperm quality may influence embryo development. However, although both gamete qualities contribute to embryonic competence, existing AI-based oocyte assessment models largely focus on maternal factors in isolation. Consequently, the extent to which sperm quality is associated with blastocyst outcomes across distinct AI-defined oocyte quality strata remains insufficiently explored. Study design, size, duration A retrospective study including 2,341 fresh metaphase II oocytes (210 ICSI cycles) was conducted between March 2024 and December 2025. Fresh ejaculated sperm were analysed according to World Health Organization (WHO) 2021 guidelines. Oocytes were imaged and scored with MAGENTA before ICSI, with scores categorised as A (7.6–10.0), B (5.1–7.5), C (2.6–5.0), or D (0.0–2.5). Following ICSI and TL culture, embryo quality was assessed on Day-5. Participants/materials, setting, methods The mean age of women was 28.54 ± 5.73 years. Patients were categorised into: normozoospermia (concentration ≥16 × 106/ml and progressive motility (PR) ≥30%), mild-to-moderate male factor (MMF; concentration 5–15 × 106/ml), and severe oligoasthenozoospermia (OAT-S;concentration<5 × 106/ml and PR < 10%). Associations between sperm quality and blastocyst outcomes were evaluated within each MAGENTA-defined oocyte score group. Blastocyst formation was defined by blastocoel presence; good-quality blastocysts as ≥ 3BB via the Gardner and Schoolcraft grading system. Main results and the role of chance Binary logistic regression was performed separately within each Magenta oocyte score group to examine associations between sperm group classification and Day-5 blastocyst development. In Magenta group A, embryos derived from the OAT-S sperm group showed significantly lower odds of blastocyst formation compared with normozoospermia (OR = 0.49, 95% CI 0.28–0.85; p = 0.012), whereas no association was observed for the MMF group. No significant associations between the three sperm groups and blastocyst formation were identified in Magenta groups B or C. In Magenta group D, embryos derived from the MMF sperm group exhibited reduced odds of blastocyst formation (OR = 0.50, 95% CI 0.30–0.84; p = 0.008). Similar patterns were observed for good-quality blastocyst development. In Magenta group A, embryos generated using OAT-S sperm had significantly lower odds of achieving good-quality blastocyst status (OR = 0.39, 95% CI 0.23–0.68;p= 0.001). In Magenta group D, embryos derived from the MMF sperm group showed reduced odds of good-quality blastocyst formation (OR = 0.52, 95% CI 0.27–0.99;p= 0.045). No significant associations between the three sperm groups and blastocyst quality were observed in Magenta groups B or C for either outcome. Limitations, reasons for caution This retrospective, single-centre analysis may limit the generalisability of the findings. In addition, clinical outcomes were not assessed. Analyses were exploratory and conducted at the oocyte level without adjustment for within-cycle clustering. Wider implications of the findings These findings highlight that sperm quality impacts blastocyst development even across AI-defined oocyte quality strata, emphasising the need to integrate both paternal and maternal factors when predicting embryo potential and counselling patients. Trial registration number No

Zitieren

APA

Yesilada, N., Atayurt, Z., Raad, G., Liperis, G., Yarkiner, Z., Ammar, O., Yilancilar, Y., Yuksel, B., & Serdarogullari, M. (2026). L26/P-060 Influence of sperm quality on blastocyst development across artificial intelligence (AI)-derived oocyte quality strata: a retrospective study. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.396

Vancouver

Yesilada N, Atayurt Z, Raad G, Liperis G, Yarkiner Z, Ammar O, et al. L26/P-060 Influence of sperm quality on blastocyst development across artificial intelligence (AI)-derived oocyte quality strata: a retrospective study. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.396

BibTeX
@article{Yesilada2026,
  author = {Yesilada, N. and Atayurt, Z. and Raad, G. and Liperis, G. and Yarkiner, Z. and Ammar, O. and Yilancilar, Y. and Yuksel, B. and Serdarogullari, M.},
  title = {L26/P-060 Influence of sperm quality on blastocyst development across artificial intelligence (AI)-derived oocyte quality strata: a retrospective study},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.396}
}
Kostenlos starten →